(Q37805788)

23 August 2017

title

The platelet contribution to cancer progression (English)

1 reference

23 August 2017

N M Bambace

1

1 reference

23 August 2017

C E Holmes

series ordinal

2

1 reference

23 August 2017

publication date

1 February 2011

1 reference

Journal of Thrombosis and Haemostasis

23 August 2017

published in

1 reference

23 August 2017

volume

9

1 reference

23 August 2017

issue

2

1 reference

23 August 2017

page(s)

237-249

1 reference

Platelets and angiogenesis in malignancy.

23 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04131.X

Platelet integrin alpha(IIb)beta(3): activation mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04131.X

Activation of platelet function through G protein-coupled receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04131.X

Characterization of the proteins released from activated platelets leads to localization of novel platelet proteins in human atherosclerotic lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04131.X

Differing platelet aggregating effects by two tumor cell lines: Absence of role for platelet‐derived ADP

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04131.X

Abnormal haemostasis in small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04131.X

Contribution of the hemostatic system to angiogenesis in cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04131.X

Antimetastatic effects associated with platelet reduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04131.X

Role of platelets in tumor cell metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04131.X

Poor prognosis associated with thrombocytosis in patients with gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04131.X

Poor prognosis associated with thrombocytosis in patients with renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04131.X

Significance of thrombocytosis in patients with epithelial ovarian cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04131.X

Platelet number and interleukin-6 correlate with VEGF but not with bFGF serum levels of advanced cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04131.X

Interleukin-6 stimulates thrombopoiesis through thrombopoietin: role in inflammatory thrombocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04131.X

Response of a human megakaryocytic cell line to thrombin: increase in intracellular free calcium and mitogen release

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04131.X

Constitutive production and thrombin-induced release of vascular endothelial growth factor by human megakaryocytes and platelets

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04131.X

Autocrine-paracrine VEGF loops potentiate the maturation of megakaryocytic precursors through Flt1 receptor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04131.X

The effect of platelets on invasiveness and protease production of human mammary tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04131.X

Integrin activation controls metastasis in human breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04131.X

Activated platelets enhance ovarian cancer cell invasion in a cellular model of metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04131.X

Platelet-derived lysophosphatidic acid supports the progression of osteolytic bone metastases in breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04131.X

Type beta transforming growth factor in human platelets: release during platelet degranulation and action on vascular smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04131.X

Contributions of stromal metalloproteinase-9 to angiogenesis and growth of human ovarian carcinoma in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04131.X

Role of adhesive proteins in platelet tumor interaction in vitro and metastasis formation in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04131.X

Platelet-mimicry of cancer cells: epiphenomenon with clinical significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04131.X

Platelet-derived transforming growth factor-beta down-regulates NKG2D thereby inhibiting natural killer cell antitumor reactivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04131.X

Platelet--cancer interactions: mechanisms and pharmacology of tumour cell-induced platelet aggregation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04131.X

Decreased platelet aggregation, increased bleeding time and resistance to thromboembolism in P2Y1-deficient mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04131.X

Central role of the P2Y12 receptor in platelet activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04131.X

Membrane type-1 matrix metalloproteinase stimulates tumour cell-induced platelet aggregation: role of receptor glycoproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04131.X

Role of thrombin in angiogenesis and tumor progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04131.X

Matrix metalloproteinases and tumor metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04131.X

Deadly allies: the fatal interplay between platelets and metastasizing cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04131.X

Blockade of GpIIb/IIIa inhibits the release of vascular endothelial growth factor (VEGF) from tumor cell-activated platelets and experimental metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04131.X

Tumor-cell-induced platelet aggregation is a glycoprotein-dependent and lipoxygenase-associated process

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04131.X

Inhibition of platelet GPIb alpha and promotion of melanoma metastasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04131.X

Platelet glycoprotein Ib alpha supports experimental lung metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04131.X

Platelet glycoprotein VI facilitates experimental lung metastasis in syngenic mouse models

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04131.X

Synergistic effects of L- and P-selectin in facilitating tumor metastasis can involve non-mucin ligands and implicate leukocytes as enhancers of metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04131.X

Endothelial P-selectin as a target of heparin action in experimental melanoma lung metastasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04131.X

P-selectin deficiency attenuates tumor growth and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04131.X

P-selectin mediates adhesion of platelets to neuroblastoma and small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04131.X

P-selectin, carcinoma metastasis and heparin: novel mechanistic connections with therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04131.X

Microparticles, thrombosis and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04131.X

Modulation of monocyte-endothelial cell interactions by platelet microparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04131.X

Transcellular activation of platelets and endothelial cells by bioactive lipids in platelet microparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04131.X

Enhancing effect of platelet-derived microvesicles on the invasive potential of breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04131.X

Microvesicles derived from activated platelets induce metastasis and angiogenesis in lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04131.X

Platelet-derived microparticles promote invasiveness of prostate cancer cells via upregulation of MMP-2 production.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04131.X

Tumor angiogenesis: therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04131.X

Inflammatory mast cells up-regulate angiogenesis during squamous epithelial carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04131.X

Activated macrophages induce vascular proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04131.X

Tamoxifen and aromatase inhibitors differentially affect vascular endothelial growth factor and endostatin levels in women with breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04131.X

The hemostatic system and angiogenesis in malignancy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04131.X

Platelet-derived thrombospondin-1 is a critical negative regulator and potential biomarker of angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04131.X

Tumors stimulate platelet delivery of angiogenic factors in vivo: an unexpected benefit

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04131.X

Angiogenesis is regulated by a novel mechanism: pro- and antiangiogenic proteins are organized into separate platelet alpha granules and differentially released

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04131.X

Proteinase-activated receptors 1 and 4 counter-regulate endostatin and VEGF release from human platelets

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04131.X

The effect of P2Y-mediated platelet activation on the release of VEGF and endostatin from platelets

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04131.X

Hemostatic regulators of tumor angiogenesis: a source of antiangiogenic agents for cancer treatment?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04131.X

Platelets actively sequester angiogenesis regulators

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04131.X

Arterio-venous gradients of IL-6, plasma and serum VEGF and D-dimers in human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04131.X

Evidence that platelets promote tube formation by endothelial cells on matrigel.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04131.X

Platelets and platelet adhesion support angiogenesis while preventing excessive hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04131.X

Platelet-endothelial interaction in tumor angiogenesis and microcirculation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04131.X

21 January 2018

Inflammation and cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04131.X

P2Y purinergic receptors regulate the growth of human melanomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04131.X

Purinergic regulation of vascular endothelial growth factor signaling in angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04131.X

Purinergic regulation of angiogenesis by human breast carcinoma-secreted nucleoside diphosphate kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04131.X

Thrombin generation and the pathogenesis of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04131.X

Tissue factor and PAR2 signaling in the tumor microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04131.X

Comparison of tumor and microenvironment secretomes in plasma and in platelets during prostate cancer growth in a xenograft model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04131.X

Platelet-associated PF-4 as a biomarker of early tumor growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04131.X

Platelets: guardians of tumor vasculature

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04131.X

Platelet granule secretion continuously prevents intratumor hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04131.X

Innate immune cells induce hemorrhage in tumors during thrombocytopenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04131.X

TREM-like transcript-1 protects against inflammation-associated hemorrhage by facilitating platelet aggregation in mice and humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04131.X

Mac-1 (CD11b/CD18) links inflammation and thrombosis after glomerular injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04131.X

Inflammation induces hemorrhage in thrombocytopenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04131.X

Placebo-controlled study on the efficacy of the pyrimido-pyrimidine derivative RA 233 in ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04131.X

Effect of mopidamol on survival in carcinoma of the lung and colon: final report of Veterans Administration Cooperative Study No. 188.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04131.X

Aspirin for the chemoprevention of colorectal adenomas: meta-analysis of the randomized trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04131.X

Moderation of the platelet releasate response by aspirin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04131.X

Platelet—tumor-cell interactions in mice. The role of platelets in the spread of malignant disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04131.X

Suppression of lung metastasis by aspirin but not indomethacin in an in vivo model of chemically induced hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04131.X

Aspirin and non-small cell lung cancer resections: effect on long-term survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04131.X

Aspirin intake and survival after breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04131.X

Inhibition of metastasis in a murine 4T1 breast cancer model by liposomes preventing tumor cell-platelet interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04131.X

Inhibition of breast cancer metastasis by dual liposomes to disturb complex formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04131.X

Anti-angiogenic effects of the thienopyridine SR 25989 in vitro and in vivo in a murine pulmonary metastasis model

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04131.X

The bidirectional relationship of cancer and hemostasis and the potential role of anticoagulant therapy in moderating thrombosis and cancer spread

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04131.X

Platelet and osteoclast β 3 integrins are critical for bone metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04131.X

APT102, a novel adpase, cooperates with aspirin to disrupt bone metastasis in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04131.X

Platelets, protease-activated receptors, and fibrinogen in hematogenous metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04131.X

The use of anticoagulants improves biochemical control of localized prostate cancer treated with radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04131.X

Release of gelatinase A during platelet activation mediates aggregation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.04131.X

10.1111/J.1538-7836.2010.04131.X

21 January 2018

Identifiers

DOI

1 reference

23 August 2017

1 reference